Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 118-121, January 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenzie, D.
Right arrow Articles by Brody, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenzie, D.
Right arrow Articles by Brody, J. I.

Synergistic Toxicity of Triethylene Thiophosphoramide and Folic Acid in the IRC 741 Leukemia*

Doris McKenzie{dagger} and Jerome I. Brody{ddagger}

( Department of Medicine, Veterans Administration Hospital, and the University of Miami School of Medicine, Coral Gables, Florida)

The purpose of this study was to determine the influence of folic acid or vitamin B-12 on the course of the IRC 741 rat leukemia treated with thioTEPA. On the first day immediately following tumor implantation into Fischer rats individual series of these animals were given 6 mg/kg thioTEPA, in a single injection, or 1 mg/kg, every other day for six doses without and with simultaneous injections of folic acid or vitamin B-12. ThioTEPA alone, in multiple doses, increased the rat survival time, but these animals eventually died of leukemia. ThioTEPA in a single injection, although more toxic, nevertheless produced remissions consistent with experimental cure. The most important observation, however, was that the concomitant administration of folic acid and a single dose of thioTEPA was associated with premature death of all animals so treated, suggesting that under certain experimental conditions folic acid may interfere with the ameliorative or curative properties of this particular antileukemic agent. Vitamin B-12 appeared inactive in this experimental system.

* Presented in part to the National Meeting of the American Association for Cancer Research, Atlantic City, New Jersey, April 15, 1962.

{dagger} United States Public Health Service Research Fellow in Hematology. Present Address: Jackson Memorial Hospital, Miami, Florida.

{ddagger} Present address: The Graduate Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Received 7/ 9/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.